The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France
Tóm tắt
In psoriatic arthritis (PsA) almost all qualitative studies have been performed in European populations. This work aimed to evaluate the impact of PsA in Brazilian and French subjects, as well as to explore cultural differences in the experience of disease and to recognize domains important for patients living with PsA outside Europe. A qualitative study was conducted in two university hospitals in Brazil and France; outpatients fulfilling Classification Criteria for PsA participated in individual interviews regarding the impact of PsA; interviews were conducted in the local language. The sample size was defined by saturation; interviews were recorded and transcribed and content analysis was performed. Fifteen patients were interviewed in Brazil and 13 in France. Mean disease duration was 16.5 ± 12.5 years (range: 8 months to 47 years) and 14.4 ± 8.4 years (range 12 months to 29 years) for Brazilian and French subjects, respectively. A broad impact was perceived: 67 codes emerged from the interviews and were grouped in 41 categories. Although 2/3 of categories were common to both nationalities, some important health domains from the perspective of PsA patients from a non-European background were brought to light including sexual dysfunction, emotional impact of psoriasis and impact of prejudice on social and professional life. This study highlights the importance of assessing the impact of PsA on a national level, emphasizing the common cross-cultural aspects but also revealing domains of interest for patients with PsA living outside Europe which merit further study.
Tài liệu tham khảo
Tezel N, Yilmaz Tasdelen O, Bodur H, Gul U, Kulcu Cakmak S, Oguz ID, et al. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Int J Rheum Dis. 2015;18:63–9.
Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol. 2001;28:1842–6.
Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001;45:151–8.
Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Rheumatol Ter. 2016;3:91–102.
Hagberg KW, Li L, Peng M, Shah K, Paris M, Jick S. Incidence rates of suicidal behaviors and treated depression in patients with and without psoriatic arthritis using the Clinical Practice Research Datalink. Mod Rheumatol. 2016;26:774–9.
Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete J, et al. Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care Res (Hoboken). 2016. https://doi.org/10.1002/acr.23172 [Epub ahead of print].
Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012–9.
Stam TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Care Res. 2007;57:487–94.
Gudu T, Kiltz U, de Wit M, Kvien TK, Gossec L. Mapping the Effect of Psoriatic Arthritis Using the International Classification of Functioning, Disability and Health. J Rheumatol. 2017;44:193–200.
Torre-Alonso JC, Gratacós J, Rey-Rey JS, Valdazo de Diego JP, Urriticoechea-Arana A, Daudén E, et al. Development and validation of a new instrument to measure health-related quality of life in patients with psoriatic arthritis: the VITACORA-19. J Rheumatol. 2014;41:2008–17.
Billing E, McKenna SP, Staun M, Lindqvist U. Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) instrument for Sweden. Scand J Rheumatol. 2010;39:223–8.
McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004;63:162–9.
Wink F, Arends S, McKenna SP, Houtman PM, Brouwer E, Spoorenberg A. Validity and reliability of the Dutch adaptation of the psoriatic arthritis quality of life (PsAQoL) questionnaire. PLoS One. 2013;8:e55912.
Chisholm A, Pearce CJ, Chinoy H, Warren RB, Bundy C. Distress, misperceptions, poor coping and suicidal ideation in psoriatic arthritis: a qualitative study. Rheumatology (Oxford). 2016; [Epub ahead of print].
Stam T, Hieblinger R, Boström C, Mihai C, Birrell F, Thorstensson C, et al. Similar problem in the activities of daily living but different experience: a qualitative analysis in six rheumatic conditions and eight European countries. Musculoskelet Care. 2014;12:22–33.
Moverley AR, Vinall-Collier KA, Helliwell PS. It’s not just the joints, it’s the whole thing: qualitative analysis of patients’s experience of flare in psoriatic arthritis. Rheumatology (Oxford). 2015;54:1448–53.
Kumar K, Gordon C, Barry R, Shaw K, Horne R, Raza K. ‘It’s like taking poison to kill poison but I have to get better’: a qualitative study of beliefs about medicines in rheumatoid arthritis and systemic lupus erythematosus patients of south Asian origin. Lupus. 2011;20:837–44.
Sanderson T, Calnan M, Kumar K. The moral experience of illness and its impact on normalisation: examples from narratives with Punjabi women living with rheumatoid arthritis in the UK. Sociol Heal Illn. 2015;37(8):1218–35.
Kumar K, Gordon C, Toescu V, Buckley CD, Horne R, Nightingale PG, et al. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin. Rheumatology (Oxford). 2008;47:690–7.
Wen H, Ralph Schumacher H, Li X, Gu J, Ma L, Wei H, et al. Comparison of expectations of physicians and patients with rheumatoid arthritis for rheumatology clinic visits: a pilot, multicenter, international study. Int J Rheum Dis. 2012;15:380–9.
Ribeiro SL, Albuquerque EN, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, et al. Quality of life in spondyloarthritis: analysis of a large Brazilian cohort. Rev Bras Reumatol. 2016;56:22–7.
da Costa IP, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, Bértolo MB, et al. Evaluation of performance of BASDAI (Bath ankylosing spondylitis disease activity index) in Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian registry of Spondyloarthritides (RBE). Rev Bras Reumatol. 2015;55:48–54.
Nota I, Drossaert CH, Taal E, Vonkeman HE, van de Laar MA. Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey. BMC Musculoskelet Disord. 2014;15:333.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–73.
Depoy E, Gitlin LN. Introduction to research. St. Louis: Mosby; 1998.
Bruce B, Fries JF. The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167–78.
Szentpetery A, Johnson MAN, Ritchlin CT. GRAPPA Trainees Symposium 2013: A Report from the GRAPPA 2013 Annual Meeting. J Rheumatol. 2014;41:1200–5.
Crabtree B, Miller W. Doing qualitative research. London: SAGE; 1999. p. 406.
Hewlett S, Nicklin J, Bode C, Carmona L, Dures E, Engelbrecht M, et al. Translating patient reported outcome measures: methodological issues explored using cognitive interviewing with three rheumatoid arthritis measures in six European languages. Rheumatology (Oxford). 2016;55:1009–16.
Kalyoncu U, Ogdie A, Campbell W, Bingham CO 3rd, de Wit M, Gladman DD, et al. Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open. 2016;2:e000217.
Palominos PE, Gaujoux-Viala C, Fautrel B, Dougados M, Gossec L. Clinical outcomes in psoriatic arthritis: A systematic literature review. Arthritis Care Res (Hoboken). 2012;64:397–406.
Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2016. https://doi.org/10.1136/annrheumdis-2016-210242 [Epub ahead of print].
Hunt SM, McKenna SP, MEwen J, Backtt EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health. 1980;34:281–6.
Kurizky PS, Mota LM. Sexual dysfunction in patients with psoriasis and psoriatic arthritis - a systematic review. Rev Bras Reumatol. 2012;52:943–8.
Halioua B, Sid-Mohand D, Roussel ME, Maury-le-Breton A, de Fontaubert A, Stalder JF. Extent of misconceptions, negative prejudices and discriminatory behaviour to psoriasis patients in France. J Eur Acad Dermatol Venereol. 2016;30:650–4.
Uttjek M, Nygren L, Stenberg B, Dufåker M. Marked by visibility of psoriasis in everyday life. Qual Health Res. 2007;17:364–72.